{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:50:01Z","timestamp":1793386201466,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2321-B-002-006"],"award-info":[{"award-number":["108-2321-B-002-006"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2320-B-002-013"],"award-info":[{"award-number":["109-2320-B-002-013"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2320-B-002-036"],"award-info":[{"award-number":["110-2320-B-002-036"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2320-B-002-035-MY3"],"award-info":[{"award-number":["111-2320-B-002-035-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["110-O09"],"award-info":[{"award-number":["110-O09"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["111-S0053"],"award-info":[{"award-number":["111-S0053"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Human enteroviruses A71 (EV-A71) and D68 (EV-D68) are the suspected causative agents of hand-foot-and-mouth disease, aseptic meningitis, encephalitis, acute flaccid myelitis, and acute flaccid paralysis in children. Until now, no cure nor mucosal vaccine existed for EV-A71 and EV-D68. Novel mucosal bivalent vaccines are highly important for preventing EV-A71 and EV-D68 infections.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, formalin-inactivated EV-A71 and EV-D68 were used as antigens, while PS-G, a polysaccharide from <jats:italic>Ganoderma lucidum<\/jats:italic>, was used as an adjuvant. Natural polysaccharides have the characteristics of intrinsic immunomodulation, biocompatibility, low toxicity, and safety. Mice were immunized intranasally with PBS, EV-A71, EV-D68, or EV-A71\u2009+\u2009EV-D68, with or without PS-G as an adjuvant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The EV-A71\u2009+\u2009EV-D68 bivalent vaccine generated considerable EV-A71- and EV-D68-specific IgG and IgA titres in the sera, nasal washes, saliva, bronchoalveolar lavage fluid, and feces. These antibodies neutralized EV-D68 and EV-A71 infectivity. They also cross-neutralized infections by different EV-D68 and EV-A71 sub-genotypes. Furthermore, compared with the PBS group, EV-A71\u2009+\u2009EV-D68\u2009+\u2009PS-G-vaccinated mice exhibited an increased number of EV-D68- and EV-A71-specific IgA- and IgG-producing cells. In addition, T-cell proliferative responses, and IFN-\u03b3 and IL-17 secretion in the spleen were substantially induced when PS-G was used as an adjuvant with EV-A71\u2009+\u2009EV-D68. Finally, in vivo challenge experiments demonstrated that the immune sera induced by EV-A71\u2009+\u2009EV-D68\u2009+\u2009PS-G conferred protection in neonate mice against lethal EV-A71 and EV-D68 challenges as indicated by the increased survival rate and decreased clinical score and viral RNA tissue expression. Taken together, all EV-A71\/EV-D68\u2009+\u2009PS-G-immunized mice developed potent specific humoral, mucosal, and cellular immune responses to EV-D68 and EV-A71 and were protected against them.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings demonstrated that PS-G can be used as a potential adjuvant for EV-A71 and EV-D68 bivalent mucosal vaccines. Our results provide useful information for the further preclinical and clinical development of a mucosal bivalent enterovirus vaccine against both EV-A71 and EV-D68 infections.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12929-023-00987-3","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T17:02:51Z","timestamp":1702918971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A novel mucosal bivalent vaccine of EV-A71\/EV-D68 adjuvanted with polysaccharides from Ganoderma lucidum protects mice against EV-A71 and EV-D68 lethal challenge"],"prefix":"10.1186","volume":"30","author":[{"given":"Yu-Li","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Li","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Ting","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Kei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siao-Cian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6705-0286","authenticated-orcid":false,"given":"Bor-Luen","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"987_CR1","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1099\/vir.0.79925-0","volume":"85","author":"MS Oberste","year":"2004","unstructured":"Oberste MS, Maher K, Schnurr D, Flemister MR, Lovchik JC, Peters H, et al. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J Gen Virol. 2004;85:2577\u201384.","journal-title":"J Gen Virol"},{"key":"987_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1126\/science.1261962","volume":"347","author":"Y Liu","year":"2015","unstructured":"Liu Y, Sheng J, Fokine A, Meng G, Shin W-H, Long F, et al. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science. 2015;347:71\u20134.","journal-title":"Science"},{"key":"987_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fmicb.2018.00286","volume":"9","author":"J Yuan","year":"2018","unstructured":"Yuan J, Shen L, Wu J, Zou X, Gu J, Chen J, et al. Enterovirus A71 proteins: structure and function. Front Microbiol. 2018;9:286.","journal-title":"Front Microbiol"},{"key":"987_CR4","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1513\/AnnalsATS.201412-592FR","volume":"12","author":"CM Oermann","year":"2015","unstructured":"Oermann CM, Schuster JE, Conners GP, Newland JG, Selvarangan R, Jackson MA. Enterovirus D68. A focused review and clinical highlights from the 2014 U.S. Outbreak. Ann Am Thorac Soc. 2015;12:775\u201381.","journal-title":"Ann Am Thorac Soc"},{"key":"987_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/infdis\/129.3.304","volume":"129","author":"NJ Schmidt","year":"1974","unstructured":"Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129:304\u20139.","journal-title":"J Infect Dis"},{"key":"987_CR6","doi-asserted-by":"publisher","first-page":"19780","DOI":"10.3402\/ehtj.v6i0.19780","volume":"6","author":"CCY Yip","year":"2013","unstructured":"Yip CCY, Lau SKP, Woo PCY, Yuen KY. Human enterovirus 71 epidemics: what\u2019s next? Emerg Health Threats J. 2013;6:19780.","journal-title":"Emerg Health Threats J"},{"key":"987_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1875-9572(08)60023-6","volume":"49","author":"LY Chang","year":"2008","unstructured":"Chang LY. Enterovirus 71 in Taiwan. Pediatr Neonatol. 2008;49:103\u201312.","journal-title":"Pediatr Neonatol"},{"key":"987_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12929-019-0573-2","volume":"26","author":"J Puenpa","year":"2019","unstructured":"Puenpa J, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. The history of Enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific region. J Biomed Sci. 2019;26:75.","journal-title":"J Biomed Sci"},{"key":"987_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/oxfordjournals.aje.a120693","volume":"85","author":"JH Schieble","year":"1967","unstructured":"Schieble JH, Fox VL, Lennette EH. A probable new human picornavirus associated with respiratory diseases. Am J Epidemiol. 1967;85:297\u2013310.","journal-title":"Am J Epidemiol"},{"key":"987_CR10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/cid\/ciw372","volume":"63","author":"JJ Sejvar","year":"2016","unstructured":"Sejvar JJ, Lopez AS, Cortese MM, Leshem E, Pastula DM, Miller LA, et al. Acute flaccid myelitis in the United States, August\u2013December 2014: Results of Nationwide Surveillance. Clin Infect Dis. 2016;63:737\u201345.","journal-title":"Clin Infect Dis"},{"key":"987_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/MOP.0000000000000303","volume":"28","author":"D Lugo","year":"2016","unstructured":"Lugo D, Krogstad P. Enteroviruses in the early 21st century: new manifestations and challenges. Curr Opin Pediatr. 2016;28:107\u201313.","journal-title":"Curr Opin Pediatr"},{"key":"987_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/rmv.1820","volume":"25","author":"T Imamura","year":"2014","unstructured":"Imamura T, Oshitani H. Global reemergence of enterovirus D68 as an important pathogen for acute respiratory infections. Rev Med Virol. 2014;25:102\u201314.","journal-title":"Rev Med Virol"},{"key":"987_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3949\/ccjm.82a.14166","volume":"82","author":"CB Foster","year":"2015","unstructured":"Foster CB, Friedman N, Carl J, Piedimonte G. Enterovirus D68: a clinically important respiratory enterovirus. Cleve Clin J Med. 2015;82:26\u201331.","journal-title":"Cleve Clin J Med"},{"key":"987_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jcv.2015.06.079","volume":"69","author":"A Levy","year":"2015","unstructured":"Levy A, Roberts JA, Lang J, Tempone S, Kesson A, Dofai A, et al. Enterovirus D68 disease and molecular epidemiology in Australia. J Clin Virol. 2015;69:117\u201321.","journal-title":"J Clin Virol"},{"key":"987_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jmii.2015.07.015","volume":"50","author":"YP Huang","year":"2017","unstructured":"Huang YP, Lin TL, Lin TH, Wu HS. Molecular and epidemiological study of enterovirus D68 in Taiwan. J Microbiol Immunol Infect. 2017;50:411\u20137.","journal-title":"J Microbiol Immunol Infect"},{"key":"987_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1586\/14760584.2016.1138862","volume":"15","author":"Q Mao","year":"2016","unstructured":"Mao Q, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev Vaccines. 2016;15:599\u2013606.","journal-title":"Expert Rev Vaccines"},{"key":"987_CR17","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/S0140-6736(22)00380-4","volume":"399","author":"H Nguyen-Tran","year":"2022","unstructured":"Nguyen-Tran H, Messacar K. Preventing enterovirus A71 disease: another promising vaccine for children. Lancet. 2022;399:1671\u20133.","journal-title":"Lancet"},{"key":"987_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.imlet.2009.10.005","volume":"128","author":"R Brunner","year":"2010","unstructured":"Brunner R, Jensen-Jarolim E, Pali-Sch\u00f6ll I. The ABC of clinical and experimental adjuvants\u2014a brief overview. Immunol Lett. 2010;128:29\u201335.","journal-title":"Immunol Lett"},{"key":"987_CR19","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1248\/cpb.29.3611","volume":"29","author":"T Miyazaki","year":"1981","unstructured":"Miyazaki T, Nishijima M. Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem Pharm Bull (Tokyo). 1981;29:3611\u20136.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"987_CR20","doi-asserted-by":"publisher","first-page":"153473541989091","DOI":"10.1177\/1534735419890917","volume":"18","author":"QH Zhang","year":"2019","unstructured":"Zhang QH, Hu QX, Xie D, Chang BJ, Miao H, Wang Y, et al. Ganoderma lucidum exerts an anticancer effect on human osteosarcoma cells via suppressing the Wnt\/\u03b2-Catenin signaling pathway. Integr Cancer Ther. 2019;18:1534735419890917.","journal-title":"Integr Cancer Ther"},{"key":"987_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1189\/jlb.0804481","volume":"78","author":"YL Lin","year":"2005","unstructured":"Lin YL, Liang YC, Lee SS, Chiang BL. Polysaccharide purified fromGanoderma luciduminduced activation and maturation of human monocyte-derived dendritic cells by the NF-\u03baB and p38 mitogen-activated protein kinase pathways. J Leukoc Biol. 2005;78:533\u201343.","journal-title":"J Leukoc Biol"},{"key":"987_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1124\/mol.106.022327","volume":"70","author":"YL Lin","year":"2006","unstructured":"Lin YL, Lee SS, Hou SM, Chiang BL. Polysaccharide purified from Ganoderma lucidum induces gene expression changes in human dendritic cells and promotes T helper 1 immune response in BALB\/c mice. Mol Pharmacol. 2006;70:637\u201344.","journal-title":"Mol Pharmacol"},{"key":"987_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.561758","volume":"11","author":"YL Lin","year":"2020","unstructured":"Lin YL, Shih C, Cheng PY, Chin CL, Liou AT, Lee PY, et al. A polysaccharide purified from Ganoderma lucidum acts as a potent mucosal adjuvant that promotes protective immunity against the lethal challenge with Enterovirus A71. Front Immunol. 2020;11: 561758.","journal-title":"Front Immunol"},{"key":"987_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/14760584.2016.1191357","volume":"15","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Li J, Jin P, Wang Y, Zhu F. Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine. Expert Rev Vaccines. 2016;15:803\u201313.","journal-title":"Expert Rev Vaccines"},{"key":"987_CR25","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/S0140-6736(22)00313-0","volume":"399","author":"TT Nguyen","year":"2022","unstructured":"Nguyen TT, Chiu CH, Lin CY, Chiu NC, Chen PY, Le TT, et al. Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet. 2022;399:1708\u201317.","journal-title":"Lancet"},{"key":"987_CR26","doi-asserted-by":"publisher","first-page":"7916","DOI":"10.1128\/JVI.78.15.7916-7924.2004","volume":"78","author":"YF Wang","year":"2004","unstructured":"Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, et al. A mouse-adapted Enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78:7916\u201324.","journal-title":"J Virol"},{"key":"987_CR27","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1016\/j.vaccine.2018.05.090","volume":"36","author":"YL Lin","year":"2018","unstructured":"Lin YL, Cheng PY, Chin CL, Huang LM, Lin SY, Chiang BL. Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine. Vaccine. 2018;36:4331\u20138.","journal-title":"Vaccine"},{"key":"987_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/(SICI)1097-0215(19970317)70:6<699::AID-IJC12>3.0.CO;2-5","volume":"70","author":"SY Wang","year":"1997","unstructured":"Wang SY, Hsu ML, Hsu HC, Lee SS, Shiao MS, Ho CK. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer. 1997;70:699\u2013705.","journal-title":"Int J Cancer"},{"key":"987_CR29","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1038\/s41598-018-28281-5","volume":"8","author":"YL Lin","year":"2018","unstructured":"Lin YL, Chow YH, Huang LM, Hsieh SM, Cheng PY, Hu KC, et al. A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge. Sci Rep. 2018;8:10713.","journal-title":"Sci Rep"},{"key":"987_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1208\/s12249-022-02425-3","volume":"23","author":"S Ma","year":"2022","unstructured":"Ma S, Yu R, Mai Y, Yu N, Gao T, Yang J. Enhanced influenza immunity by nasal mucosal administration of the TPGS-modified liposomal vaccine. AAPS PharmSciTech. 2022;23:272.","journal-title":"AAPS PharmSciTech"},{"key":"987_CR31","doi-asserted-by":"publisher","first-page":"eadd9947","DOI":"10.1126\/sciimmunol.add9947","volume":"7","author":"EJ Topol","year":"2022","unstructured":"Topol EJ, Iwasaki A. Operation nasal vaccine\u2014lightning speed to counter COVID-19. Sci Immunol. 2022;7:eadd9947.","journal-title":"Sci Immunol"},{"key":"987_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF02786362","volume":"16","author":"HY Wu","year":"1997","unstructured":"Wu HY, Russell MW. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system. Immunol Res. 1997;16:187\u2013201.","journal-title":"Immunol Res"},{"key":"987_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0167-5699(92)90158-4","volume":"13","author":"CF Kuper","year":"1992","unstructured":"Kuper CF, Koornstra PJ, Hameleers DM, Biewenga J, Spit BJ, Duijvestijn AM, et al. The role of nasopharyngeal lymphoid tissue. Immunol Today. 1992;13:219\u201324.","journal-title":"Immunol Today"},{"key":"987_CR34","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","volume":"13","author":"PA Patriarca","year":"1991","unstructured":"Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis. 1991;13:926\u201339.","journal-title":"Rev Infect Dis"},{"key":"987_CR35","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.vaccine.2005.09.029","volume":"24","author":"S Kitchener","year":"2006","unstructured":"Kitchener S, Nissen M, Nasveld P, Forrat R, Yoksan S, Lang J, et al. Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults. Vaccine. 2006;24:1238\u201341.","journal-title":"Vaccine"},{"key":"987_CR36","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1089\/aid.2016.0299","volume":"33","author":"GK Lewis","year":"2017","unstructured":"Lewis GK, Pazgier M, Evans DT, Ferrari G, Bournazos S, Parsons MS, et al. Beyond viral neutralization. AIDS Res Hum Retroviruses. 2017;33:760\u20134.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"987_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118739","volume":"276","author":"X Wan","year":"2022","unstructured":"Wan X, Yin Y, Zhou C, Hou L, Cui Q, Zhang X, et al. Polysaccharides derived from Chinese medicinal herbs: a promising choice of vaccine adjuvants. Carbohydr Polym. 2022;276: 118739.","journal-title":"Carbohydr Polym"},{"key":"987_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-0716-1892-9_8","volume":"2412","author":"FZ Firdaus","year":"2022","unstructured":"Firdaus FZ, Skwarczynski M, Toth I. Developments in vaccine adjuvants. Methods Mol Biol. 2022;2412:145\u201378.","journal-title":"Methods Mol Biol"},{"key":"987_CR39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1189\/jlb.72.1.207","volume":"72","author":"MJ Hsu","year":"2002","unstructured":"Hsu MJ, Lee SS, Lin WW. Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase\/Akt signaling pathway. J Leukoc Biol. 2002;72:207\u201316.","journal-title":"J Leukoc Biol"},{"key":"987_CR40","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ijbiomac.2018.03.054","volume":"114","author":"Y Liu","year":"2018","unstructured":"Liu Y, Tang Q, Zhang J, Xia Y, Yang Y, Wu D, et al. Triple helix conformation of \u03b2-d-glucan from Ganoderma lucidum and effect of molecular weight on its immunostimulatory activity. Int J Biol Macromol. 2018;114:1064\u201370.","journal-title":"Int J Biol Macromol"},{"key":"987_CR41","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.3390\/nu11071480","volume":"11","author":"Q Huang","year":"2019","unstructured":"Huang Q, Li L, Chen H, Liu Q, Wang Z. GPP (Composition of Ganoderma lucidum poly-saccharides and polyporus umbellatus poly-saccharides) enhances innate immune function in mice. Nutrients. 2019;11:1480.","journal-title":"Nutrients"},{"key":"987_CR42","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ijbiomac.2014.01.067","volume":"65","author":"P Zhang","year":"2014","unstructured":"Zhang P, Ding R, Jiang S, Ji L, Pan M, Liu L, et al. The adjuvanticity of Ganoderma lucidum polysaccharide for Newcastle disease vaccine. Int J Biol Macromol. 2014;65:431\u20135.","journal-title":"Int J Biol Macromol"},{"key":"987_CR43","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.ijbiomac.2019.09.079","volume":"141","author":"Z Liu","year":"2019","unstructured":"Liu Z, Zhu T, He J, Zhang Y, Gu P, Qiu T, et al. Adjuvanticity of Ganoderma lucidum polysaccharide liposomes on porcine circovirus type-II in mice. Int J Biol Macromol. 2019;141:1158\u201364.","journal-title":"Int J Biol Macromol"},{"key":"987_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.0105-2896.2005.00283.x","volume":"206","author":"P Brandtzaeg","year":"2005","unstructured":"Brandtzaeg P, Johansen F-E. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev. 2005;206:32\u201363.","journal-title":"Immunol Rev"},{"key":"987_CR45","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/COH.0b013e328335c2f6","volume":"5","author":"L Guglani","year":"2010","unstructured":"Guglani L, Khader SA. Th17 cytokines in mucosal immunity and inflammation. Curr Opin HIV AIDS. 2010;5:120\u20137.","journal-title":"Curr Opin HIV AIDS"},{"key":"987_CR46","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","volume":"50","author":"MJ McGeachy","year":"2019","unstructured":"McGeachy MJ, Cua DJ, Gaffen SL. The IL-17 family of cytokines in health and disease. Immunity. 2019;50:892\u2013906.","journal-title":"Immunity"},{"key":"987_CR47","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1128\/JVI.00434-09","volume":"83","author":"YW Lin","year":"2009","unstructured":"Lin YW, Chang KC, Kao CH, Chang SP, Tung YY, Chen SH. Lymphocyte and antibody responses reduce Enterovirus 71 lethality in mice by decreasing tissue viral loads. J Virol. 2009;83:6477\u201383.","journal-title":"J Virol"},{"key":"987_CR48","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.vaccine.2022.12.006","volume":"41","author":"E Siena","year":"2023","unstructured":"Siena E, Schiavetti F, Borgogni E, Taccone M, Faenzi E, Brazzoli M, et al. Systems analysis of human responses to an aluminium hydroxide-adsorbed TLR7 agonist (AS37) adjuvanted vaccine reveals a dose-dependent and specific activation of the interferon-mediated antiviral response. Vaccine. 2023;41:724\u201334.","journal-title":"Vaccine"},{"key":"987_CR49","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/14760584.2021.1927724","volume":"20","author":"B Temizoz","year":"2021","unstructured":"Temizoz B, Ishii KJ. Type I and II interferons toward ideal vaccine and immunotherapy. Expert Rev Vaccines. 2021;20:527\u201344.","journal-title":"Expert Rev Vaccines"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-023-00987-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-023-00987-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-023-00987-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T17:03:21Z","timestamp":1702919001000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-023-00987-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1186\/s12929-023-00987-3","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,18]]},"assertion":[{"value":"27 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were approved by the Institutional Animal Care and Use Committee (Approval No: 20160347) at the College of Medicine, National Taiwan University (Taipei, Taiwan).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}